SNDX

Syndax Pharmaceuticals, Inc.

19.92 USD
+0.12 (+0.61%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Syndax Pharmaceuticals, Inc. stock is down -1.78% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 55.56% of the previous 8 June’s closed higher than May. In the last 3 Unusual Options Trades, there were 2 CALLs, 1 PUT. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
09 May 14:56 16 Jan, 2026 25.00 CALL 45 4
14 May 19:50 17 May, 2024 22.50 PUT 700 98
12 Jun 17:24 19 Jul, 2024 22.50 CALL 414 69

About Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals, Inc. develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein.

  • HC Wainwright & Co.
    Mon Jun 17, 06:32
    buy
    confirm
  • HC Wainwright & Co.
    Thu Jun 6, 10:10
    buy
    confirm